Fig. 3: DLCS risk score for BMFS.
(a) and (b) are risk stratification and distribution of clinical-imaging characteristics of high- and low-risk patients with BM among internal and external validation cohorts, respectively.
Fig. 3: DLCS risk score for BMFS. | npj Precision Oncology
